Clinical trial

OraQuick® HIV Self-Test Study in Canada

NCT05020353

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-06-21

PhaseNA

Study timeline

Study start (actual)2022-06-21Date precision: day

Registry last updated2025-05-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Testingunresolved

HIV Infectionsunresolved

Interventions

OraQuick® HIV Self-TestDEVICE

Sponsors & collaborators

Unity Health Torontolead sponsor

Canadian Institutes of Health Research (CIHR)collaborator

Mapped research locations

TorontoOntario, Canada3 MontrealQuebec, Canada1 VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 WinnipegManitoba, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05020353 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.